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Understanding HIV/AIDS in the African Context
Abstract
This book of readings is intended for courses in Global Health. The editors asked Prof. Stillwaggon to
contribute a chapter summarizing her years of work on the spread of HIV/AIDS in populations among whom
bacterial, fungal, parasitic, and viral diseases are extremely common, particularly in sub-Saharan Africa. Her
work has demonstrated that differences in behavior cannot explain differences in HIV rates between world
regions.
Keywords




Foundations of Global Health: An Interdisciplinary Reader is a collection of highly readable articles with a
significant amount of original text by the editors. Supplementary instructive materials include "conceptual
tools" summaries, background information on authors and context, provocative section and article
introductions, discussion questions, and suggestions for further reading and internet exploration. Like the
field of global health itself, the readings focus on the public health challenges faced by low- and middle-
income countries as well as the persistent problems of health disparities in high-income countries.











Oxford University Press is a department of the University of Oxford. It furthers 
the University's objective of excellence in research, scholarship, and education by 
publishing worldwide. Oxford is a registered trade mark of Oxford University Press 
in the UK and certain other countries.
Published in the United States of America by Oxford University Press 
198 Madison Avenue, New York, NY 10016, United States of America.
® 2019 by Oxford University Press
For titles covered by Section 112 of the US Higher Education Opportunity Act, 
please visit www.oup.com/us/he for the latest information about pricing and 
alternate formats.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval 
system, or transmitted, in any form or by any means, without the prior permission 
in writing of Oxford University Press, or as expressly permitted by law, by license, or 
under terms agreed with the appropriate reproduction rights organization. Inquiries 
concerning reproduction outside the scope of the above should be sent to the Rights 
Department, Oxford University Press, at the address above.
You must not circulate this work in any other form
and you must impose this same condition on any acquirer.
Library of Congress Cataloging-in-Publication Data
Names: Brown, Peter J., editor.
Title: Foundations of global health : an interdisciplinary reader I edited by 
Peter J. Brown, Emory University, Svea Closser, Middlebury College.
Description: New York : Oxford University Press, [2019] | Includes 
bibliographical references.
Identifiers: LCCN 2017043138 | ISBN 9780190647940 (paperback : alk. paper) 
Subjects: LCSH: World health—Textbooks. | Public health—Textbooks. 
Classification: LCC RA441 .F675 2019 | DDC 362.1—dc23 
LC record available at https://lccn.loc.gov/2017043138
987654321
Printed by Sheridan Books, Inc. United States of America
EILEEN STILLWAGGON AND LARRY SAWERS
28
UNDERSTANDING HIV/AIDS IN THE AFRICAN 
CONTEXT
Note: This article should be read in conjunction with Reading 27.
Understanding HIV/AIDS in the African context is a 
complicated endeavor. This article provides a serious con­
trast to the previous reading, which emphasized the issue 
of concurrency in sexual relationships in southern Africa. 
In contrast, this article considers many broader interact­
ing factors that provided conditions to make the HIV/ 
AIDS epidemic spread in sub-Saharan Africa.
Epidemics do not occur simply because a pathogen 
crosses some geographical or biological barrier. Rather, 
the overall context must be conducive to an epidemic. This 
is one reason why epidemics are often associated with 
wars (see Reading 32).
Like other sexually transmitted infections (STIs), HIV/ 
AIDS is only partially about sex. A variety of contextual 
factors including nutrition, hygienic conditions, and pov­
erty that can constrain the behavior of individuals also 
affect disease transmission. Answering the question of why 
there is such a high rate of HIV/AIDS in sub-Saharan 
Africa requires an understanding and serious consideration 
of the contexts—both epidemiological and socio-economic. 
It is not sufficient to focus only on individual behavior. If 
we look only at individual behavior, we are likely to exag­
gerate the ability of people to make choices within particular 
social and economic contexts and also likely to underesti­
mate the power of structural violence (see Reading 34).
This article first considers the disease burden and the 
ecology of poverty in populations with high rates of HIV. 
These factors make an individual more likely to become 
infected, because undernutrition and infectious diseases, 
such as other STIs, malaria, and schistosomiasis, lead to 
burdens on a person's immune system.
The health systems in many sub-Saharan African 
countries are so inadequate that the initial arrival of HIV/ 
AIDS was barely recognized—quite unlike the United 
States. African health-care systems and epidemiological
surveillance systems are overburdened and underfunded. 
Clinics often lack simple equipment like clean hypodermic 
needles. There are so many variables interwoven in the 
causation of the HIV/AIDS epidemic that it is probably 
impossible to measure them all in randomized controlled 
studies. It is certainly the case that the most basic epide­
miological methods (like the 2*2 table) are inadequate 
for explaining the complex interaction of causes.
Science, including research on the causes of disease, 
is often polluted by the scientists' preexisting cultural as­
sumptions and prejudices. This may be the case with as­
sumptions about the sexual behavior of the other 
societies—in this case, the historical stereotype of Africans 
as hypersexualized may have led to an overemphasis on 
sexual explanations for the spread of HIV/AIDS.
This tendency to discover things that we already be­
lieve to be true is called confirmation bias. The only way 
to circumvent such bias is through repeated study and 
reanalysis. This article interrogates the concurrency hy­
pothesis by critically examining the methods used by other 
researchers. Such arguments about methods sometimes 
seem unnecessarily trivial to students. In reality, however, 
looking at the methods that studies use is critical to un­
derstanding whether their findings are actually correct.
Remember that this article should be read in con­
junction with the previous reading (Reading 27).
As you read this piece, consider the following 
questions:
• The previous article concluded with two con­
crete recommendations for future HIV/AIDS 
prevention programs, but this article does not. 
In your opinion, what do you think that the 
authors would propose as solution(s) to the 
complexity of the epidemic?
This article is original to this volume.
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• In your opinion, why has HIV/AIDS received 
more attention than "old" health challenges 
like undernutrition, malaria, schistosomiasis, 
or the neglected tropical diseases?
• Consider the difference that the authors pro­
pose between causes of cases and causes of 
incidence. Might this difference reflect the way 
that clinical doctors think, as opposed to 
people who practice public health?
• In your opinion, are there really "methodologi­
cal handcuffs" that can hamper progress in 
health improvements? If so, what is the 
solution?
• Do you think that an incomplete consideration 
of a complex web of causation, as described 
here, can be considered "false facts?"
• The authors of this article are economists. Do 
you think that this makes a difference in their 
approaches to global health?
CONTEXT
Eileen Stillwaggon is a professor of economics 
and Benjamin Franklin Professor of Arts and
Sciences at Gettysburg College. Her primary 
interest has been on the relationship between 
health and economic development, described 
in her book, Stunted Lives, Stagnant Econo­
mies: Poverty, Disease, and Underdevelopment 
(New Brunswick, NJ: Rutgers University Press, 
1998). Recognizing the problems with an indi­
vidualized behavior approach to health inter­
ventions for HIV/AIDS, she wrote AIDS and the 
Ecology of Poverty (Oxford: Oxford University 
Press, 2006)—about the same time as the pop­
ular book discussed in Reading 27. She has also 
done research on economic development in 
Native American communities and in Latin 
America. Larry Sawers is a professor of eco­
nomics at American University, Washington, 
DC. His major research interests are in the 
causes of economic underdevelopment, one of 
which is poor health, and economic develop­
ment policy. He has been a Senior Fulbright 
Scholar in Tanzania, Ecuador, and Lithuania. His 
books include The Other Argentina: The Inte­
rior and National Development (Boulder, CO: 
Westview, 1996) and Emerging Financial Mar­
kets in the Global Economy (co-editor with 
Daniel Schydlowsky and David Nickerson; River 
Edge, NJ: World Scientific, 2000).
Large events are almost never like a meteor hitting the earth. They arise over time, from multiple, 
often interacting causes. Wars result from the com­
bined effects of economic, political, and sometimes 
natural events. Famines reflect the inability to buy 
food due to income loss as well as supply factors, 
such as crop failures and logistical obstacles. Tradi­
tional epidemiology has always recognized that 
outbreaks of disease occur in a specific context of 
environmental, social, and economic conditions. 
For an individual, as for a population, "the epide­
miology of an infectious disease reflects complex 
interactions between the infectious agent, the host, 
and the environment".1
We know a great deal about why epidemics 
spread. Random introductions of pathogens into 
human populations occur continually, but they
rarely lead to epidemics or pandemics. Favorable 
conditions are necessary for a microbe to make a 
person sick or for the disease to spread throughout 
a population. Plague was introduced numerous 
times into Europe before 1348 without pandemic 
spread. But 30 years of falling per capita food con­
sumption had weakened the population and pro­
vided the conditions needed for the Black Death.2,3 
For 100 years before 1991 there was no cholera out­
break in the Americas, although cholera vibrio was 
introduced into coastal waters throughout the region 
on countless occasions. The return of cholera to the 
hemisphere followed substantial deterioration in 
sanitary conditions throughout Latin America 
during the "lost decade" of the 1980s, a period of 
economic crisis, decreased government social ex­
penditures, falling incomes, and increasing
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inequality. From one squalid slum to another, chol­
era spread north and south from Peru across Latin 
America.4
Epidemiological, clinical, and laboratory evi­
dence show that HIV infection is influenced by the 
same factors that promote transmission of other 
infectious diseases. People with nutritional deficien- 
des, with parasitic diseases, whose general health is 
poor, who have little access to health-care services, 
or who are otherwise economically disadvantaged 
have greater susceptibility to infectious diseases, 
whether they are transmitted sexually or by food, 
water, air, or other means. This essay examines the 
spread of HIV/AIDS in sub-Saharan Africa using this 
perspective, and shows how much writing about 




At the time the HIV epidemic was spreading in 
Africa, the real annual income of the average person 
in the United States was more than 60 times that of 
the average Tanzanian or Malawian.5 Calorie intake 
per person in sub-Saharan Africa had not increased 
from 1970 to 2000 and was still only 70 percent of 
the consumption level of industrialized countries. 
Public and private spending on health services in 
Canada was 200 times what it was in Ethiopia.5 Mal­
nutrition and parasite infection contribute to greater 
susceptibility to any infectious disease, including 
those transmitted sexually. There are also certain 
diseases prevalent in Africa, but rare in the rest of 
the world, that sharply increase the probability of 
transmission of HIV.
When HIV emerged in the early 1980s, it was 
barely noticed in some African countries because of 
the routine enormity of suffering. Even today, HIV 
is far from the only threat to poor people in the 
region. When the HIV epidemic was already ad­
vanced in Malawi, a study of a plantation there re­
ported three deaths per month from AIDS, certainly 
aterrible toll. But there were six non-AIDS deaths of 
adult workers per month, and 15 deaths per month 
of workers' dependents.6 HIV flourishes where 
people are dying of other diseases. That is not mere 
coincidence.
Nutrition
From 1988 to 1998, when emerging or localized HIV 
epidemics developed into generalized epidemics in 
sub-Saharan Africa, 30 percent of the population of 
the region was malnourished.7 Malnutrition in­
creases vulnerability to infectious and parasitic dis­
eases generally, increases HIV viral load and viral 
shedding, and undermines the integrity of the skin 
and mucosa, thereby increasing sexual and vertical 
transmission of HIV.8-15 (For numerous additional 
sources on nutrition, see.)16 Malnutrition alone 
cannot explain differences in HIV epidemics across 
the globe, but, given the well-understood connec­
tion between immune status and malnutrition, it 
surely played a role in accelerating the spread of HIV 
in sub-Saharan Africa.
Malaria
When generalized epidemics of HIV were develop­
ing in the region, there were nearly 200 million cases 
of malaria in Africa every year and nearly 1 million 
deaths.17-18 At the time, Uganda, Tanzania, and Mo­
zambique had the highest incidence of malaria in 
the world, and Malawi, Zambia, and Zimbabwe were 
not far behind.19 Then as now, more than 
90 percent of acute infections and deaths from ma­
laria were in sub-Saharan Africa.17 Malaria increases 
HIV viral load up to ten times for as much as seven 
weeks after an episode of fever, and that can more 
than double heterosexual transmission.20-22 An HIV- 
infected person could have elevated viral load for 
more than half of every year since people are repeat­
edly reinfected in highly endemic areas. 
Malaria also leads to anemia and impairs immune 
response, both of which make those with HIV more 
contagious.23 Malaria is especially dangerous in areas 
of southern Africa where it occurs in seasonal epi­
demics (Botswana, Zimbabwe, Swaziland, South 
Africa, and Namibia), which are also the countries 
with the highest rates of HIV.24
Helminths
Infection with helminths, or parasitic worms, im­
pairs immune response and increases HIV viral load, 
increasing transmission of HIV and accelerating pro­
gression to AIDS.25-28 Because helminth infection is 
so prevalent in sub-Saharan Africa, even a small
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additional risk of HIV transmission due to helminth 
infection could mean many additional HIV infec­
tions overall. A double-blind, controlled trial found 
that treating worm infections in HIV-infected per­
sons results in a statistically significant improvement 
in immune system functioning.29,30 That suggests 
that a simple, inexpensive (2 US cents) and effective 
deworming medication could allow HIV-infected 
people to be healthier while reducing the risk of in­
fecting a partner, especially when antiretroviral treat­
ment for HIV may be unavailable.
Schistosomiasis
Nearly 90 percent of cases of the parasitic disease, 
urogenital schistosomiasis, occur in sub-Saharan 
Africa, where it afflicts 120 million people.31,32 Schis­
tosomiasis is highly prevalent in almost every coun­
try in sub-Saharan Africa. Schistosome worms and 
their eggs colonize the reproductive tract in men and 
women, causing inflammation, viral shedding, and 
genital ulcers, all of which increase the transmission 
efficiency of HIV.33-36 In endemic areas, from 33 to 
75 percent of women have genital lesions and in­
flammation resulting from schistosome eggs.37 The 
presence of eggs causes inflammation in the urogeni­
tal system and breaches in the integrity of the epi­
thelial layer and the protective mucosal surface.32,37,38 
Women with genital ulcers of schistosomiasis have 
three to four times the risk of being infected with 
HIV as women in the same village without genital 
ulcers of schistosomiasis.37'40
Treatment with praziquantel is effective in killing 
the worms and stopping egg production and is safe 
even in pregnancy and during lactation. Lack of 
access to treatment can produce irreversible damage 
to the reproductive tract. Praziquantel costs US 
$0.30 per treatment, and even a single treatment in 
childhood can reduce adult disease by half. Fewer 
than 8 percent of people in need are treated al­
though mass drug administration is feasible and 
inexpensive.32,41
Other Sexually Transmitted Infections 
Sub-Saharan Africa has the highest burden of sexu­
ally transmitted infections (STIs) of all of the world's 
regions.19,42 In 2004, the mean burden of STIs in sub- 
Saharan Africa [measured in disability-adjusted life
years (DALYs) per 100 000] was nearly six times the 
mean burden outside the region, and all 47 sub- 
Saharan African countries for which there were data 
were among the world's 52 countries with the highest 
ST1 burden.19 Poor access to health care services, an­
tibiotics, and antivirals contributes to the persistence 
and spread of STIs in the region,43 in spite of unex­
ceptional or even conservative sexual behavior docu­
mented in empirical studies (see below).
Some STIs produce ulceration of the genitals that 
are open pathways for transmission of HIV. All sexu­
ally transmitted infections produce inflammation, 
increased HIV shedding, and increased viral load, 
all of which have been shown to increase the risk of 
HIV transmission. Numerous observational studies 
since the late 1980s demonstrate that STI coinfec­
tions make persons with HIV more contagious and 
make STI-infected persons more vulnerable to HIV 
acquisition.27,43-48 STI diagnosis and treatment have 
been standard parts of the HIV prevention toolkit 
since the 1980s.
Non-Sexual Transmission
In addition to diseases that can increase HIV trans­
mission rates during heterosexual and mother-to- 
child exposure, non-sexual modes of transmission 
could play an especially important role in sub- 
Saharan Africa and among other poor populations. 
There are numerous, common medical blood expo­
sures (for example, injections with unsterilized sy­
ringes, blood transfusions, catheter and intravenous 
placements, and internal obstetrical examinations) 
and non-medical blood exposures (for example, 
barbering and hairdressing, tattooing, scarification, 
injections given by non-medical personnel, and in­
travenous recreational drug use) that can potentially 
transmit HIV.49-51 Even if each one of those possible 
non-sexual routes of transmission produces only a 
small share of new infections, together they would 
play an important role in the epidemics of sub- 
Saharan Africa, where sterilization equipment in 
clinics could be lacking.
AIDS Policy in Africa
Since the argument above is well supported in main­
stream epidemiology and in scientific research over 
the past four decades, why is it not reflected in AIDS
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policy for sub-Saharan Africa? Why does funding 
for HIV prevention not cover prevention of co-factor 
infections, including malaria, urogenital schistoso­
miasis, and STIs?
There are several reasons for the departure of 
AIDS research from traditional epidemiology. Over 
the course of the twentieth century, the emphasis of 
medical research shifted from environmental and 
population-level factors to individual-level theories 
of disease causation,16'52-54 and that change became 
evident in the evolution of AIDS discourse towards 
a focus on individual factors, in particular sexual 
behavior. We return to those methodological issues 
later in the essay. Here we examine the overwhelm­
ing emphasis on sexual behavior in HIV-prevention 
policy.
In the 1980s and 1990s, the enormity and speed 
of the AIDS pandemic were menacing. An incurable 
disease was spreading both in the West and in 
Africa, and ignorance of Africa served to allay West­
ern fear by constructing AIDS as a disease of the 
social Other. Western stereotypes had long por­
trayed Africans as exotic and hypersexualized. No­
tions of racial difference pervaded the social science 
literature on AIDS in Africa and were especially 
explicit during the first 15 years of the epidemic. No 
one used the word race, but the notion entered into 
the discourse as "culture." Racial "science" in an 
earlier epoch and popular racial stereotypes that 
persist to the present day stress sexual differences 
between the races and portray sub-Saharan Africans 
as exotic, strange, and even disturbing.55-57
By the late 1980s, the presumption, promoted 
in scholarly and popular literature, that the 
extraordinary nature of heterosexual behavior in 
sub-Saharan Africa explained the high prevalence 
of HIV in the region became widely accepted among 
researchers and policy makers. Influential and 
frequently cited works were characterized by 
sweeping statements about pan-African sexuality, 
either without evidence or with only anecdotal 
evidence dating from the 1920s to the 1970s. 
Through suggestive language and innuendo, they 
conveyed the impression of Africans bent on self- 
destruction because of cultural factors that 
differentiated them from everyone else. (See among 
others.58,59 For extensive discussion of racial 
innuendo in AIDS discourse, see).16'60
Racial stereotypes continue to pervade Western 
culture, casting their shadow over scholarship and 
public policy, even among persons who, on a con­
scious level, vigorously and sincerely oppose racial 
discrimination. The influence of notions of "race" 
in both the popular mind and in the imagery of 
science is insidious and difficult to counter because 
so much of racial stereotyping is in the "unstated 
assumptions and unthinking responses",61 rather 
than in explicit postulates. That is aggravated by the 
tendency for both academic and journalistic writing 
about sub-Saharan Africa to consist of a "repertoire 
of amazing facts".62 Writing about sub-Saharan Af­
ricans, popular and scholarly, almost always empha­
sizes how they are different from others, not their 
commonality with people everywhere.
Western researchers, editors of academic jour­
nals, bilateral donor agencies, and international 
organizations framed the spread of AIDS in 
sub-Saharan Africa in behavioral terms, neglecting 
the health environment in which the epidemic un­
folded in the region. The power to define the causes 
of HIV in exclusively behavioral terms narrowed the 
research questions and policy responses. In spite of 
the lack of evidence, the theme in much AIDS schol­
arship and policy literature remains that "Africans 
are not like everyone else."
Inconsistencies in the Behavioral Paradigm 
Serious researchers naturally sought data on sexual 
behavior to test the proposition that differences in 
sexual behavior could explain 50-fold differences in 
HIV prevalence between some African countries and 
the rest of the world. The UN Global Programme on 
AIDS, the Demographic and Health Surveys (DHS) 
funded by USAID, and numerous other researchers 
have produced a substantial body of survey research 
on sexual behavior in Africa and elsewhere. The sur­
veys demonstrate that within every country there is 
considerable variation in sexual behavior—some 
people have many partners, for example, but most 
people have one, very few, or none—and prevalence 
of HIV across the globe and within sub-Saharan 
Africa does not correlate with patterns of risky be­
haviors. Evidence from those surveys showed that 
in sub-Saharan Africa sexual behavior was more 
conservative than in Europe, the United States, 
Canada, and Latin America, whether measured by
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average age of sexual debut, prevalence of pre- or 
extra-marital sex, average number of partners, visits 
to commercial sex workers, or average number of 
partners in one year or over a lifetime.63 64 (For ex­
tensive documentation, see).16,65
In the 1990s, a second important finding fur­
ther undermined the validity of the behavioral 
paradigm. Researchers found that HIV is not a 
particularly virulent pathogen and that per-act 
transmission rates are quite low between other­
wise healthy adults in heterosexual contacts, 
though somewhat higher during the first few 
weeks after initial infection. 66-70 Thus, empirical 
evidence on both the behavior and the biology 
needed for a behavioral explanation was lacking. 
Nevertheless, AIDS had become associated in the 
popular imagination, including that of research­
ers, as an exceptional, African behavioral phenom­
enon. Because asking how Africans are different 
from everyone else seemed so reasonable to most 
people, a new variant, the concurrency hypothesis, 
became the conventional wisdom without credible 
empirical support.
Concurrency to the Rescue
In the early 1990s, a few researchers proposed that 
long-term overlapping partnerships—also called 
multiple concurrent partnerships, or concurrency— 
might explain the difference in HIV prevalence be­
tween Africa and the rest of the world.71,72 A decade 
later, it was clear that other forms of heterosexual 
behavior could not account for the extraordinarily 
high HIV prevalence in the region, and concurrency 
emerged as the dominant explanation.73-75 It was 
argued that concurrency—in contrast to one-time 
or short-term sexual encounters—could permit suf­
ficiently frequent sexual exposures during the first 
few weeks of HIV infection, when transmission ef­
ficiency is highest, to provide the missing engine 
capable of driving the African HIV epidemics.
The promoters of this updated version of the be­
havioral paradigm asserted that long-term concur­
rent partnerships are unusually common in 
sub-Saharan Africa.73-79 Furthermore, they asserted 
that concurrent partnerships spread HIV much 
more effectively than sequential multiple partner­
ing.75 If either assertion is incorrect, then the
concurrency hypothesis fails. We argue that neither 
is correct.
Is Concurrency More Common in Sub-Saharan 
Africa?
In 2010, we reviewed more than three dozen studies 
that proponents of the concurrency hypothesis had 
presented as evidence of extraordinarily high con­
currency prevalence in sub-Saharan Africa.65 We 
found more than 100 errors in their reporting of the 
results of those surveys. Moreover, most of the sur­
veys recruited (rather than randomly sampled) a 
small number of respondents, often in a single 
neighborhood or village, so the results could not be 
generalized to the larger population.65 The few sur­
veys that randomly sampled a large population used 
a measure of concurrency that has been judged un­
reliable by the UNAIDS Reference Group on Esti­
mates, Modelling and Projections.80 None of the 
studies provided credible evidence that concurrency 
was unusually high in sub-Saharan Africa.65 In 2010, 
the DHS (Demographic and Health Surveys) began 
to measure concurrency using the questionnaire 
proposed by the UNAIDS Reference Group. There 
are now surveys from 31 countries in sub-Saharan 
Africa that interviewed a representative national 
sample of adults, all using the same definition of 
concurrency.81-82 The average prevalence of concur­
rency (having overlapping sexual partnerships 
six months prior to the interview) was 
8.3 percent for men and 1.0 percent for women, or 
4.7 percent for all adults age 15 to 49. Concurrency 
prevalence in the United States and several Euro­
pean countries is in the same range as the numbers 
from sub-Saharan Africa, though perhaps higher for 
women and lower for men.83-85
Is Concurrency Especially Effective in 
Spreading HIV?
One cannot conduct trials with humans to test if 
concurrency is an especially effective mechanism 
for spreading HIV, so to explore the issue one must 
use mathematical modeling of sexual networks, spe­
cifically using a technique called individual-based 
stochastic simulation modeling. The modeling takes 
a number of factors into account, including the aver­
age length of each partnership, the likelihood of
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forming a concurrent partnership, and the daily risk 
or probability of acquiring HIV (which in turn im­
plicitly assumes the frequency of sexual contact in 
each partnership). For the modeling to generate 
useful results, these parameters must be based on 
reasonable estimates from survey research or clinical 
studies. Early modeling appeared to show that HIV 
spreads far more rapidly with concurrent partnering 
than with serial monogamy.75 Those results were 
cited by the modelers themselves and many others 
to make the claim that concurrency explained ex­
ceptionally high rates of HIV in sub-Saharan Africa. 
That proposition soon became widely accepted.
The original model, however, depended on pa­
rameters that were simply implausible. The modelers 
assumed that every person, male or female, had sex 
with every partner every day, with up to four part­
ners. Moreover, they assumed that each day, in each 
sexual partnership, there was a 5 percent chance of 
HIV transmission. That 5 percent transmission risk 
is nearly 100 times larger than the consensus risk 
estimate of experts on the subject. Eaton and col­
leagues86 adapted the original model's code and as­
sumed an evidence-based per-day transmission risk. 
They found that HIV either does not spread through 
sexual networks at all or spreads far more slowly 
than the original model found.
We built on Eaton's work by assigning realistic 
values for other model parameters. Based on survey 
research in sub-Saharan Africa, we assumed that 
partnerships there, like everywhere else, last for 
many years. We also assumed that secondary part­
nerships have shorter durations on average and lower 
frequency of sexual contact than primary (marital 
or cohabiting) partnerships. With all of those errors 
corrected, the restructured model cannot generate 
any HIV epidemic that does not move to extinction, 
that is, the epidemic collapses on itself. That remains 
so whatever level of concurrency one assumes, even 
levels far above those considered in the original 
model and far above levels reported in the DHS sur­
veys in sub-Saharan Africa.81'82'87
: In sum, when properly measured, levels of con­
currency in sub-Saharan Africa are not unusually 
high and, when properly modeled, concurrency at 
even implausibly high levels cannot produce sustain­
able simulated HIV epidemics. Thus, the concurrency
hypothesis, the last bulwark of the behavioral para­
digm, is without empirical or theoretical validity. 
And yet, HIV-prevention policy is still rooted in a 
behavioral, rather than a biomedical model.
What Should Inform AIDS Policy?
We have discussed how Western stereotypes of a 
hypersexualized pan-African culture, rooted in a 
belief that Africans are not like other people, al­
lowed behavioral explanations to dominate the 
search for causes of high rates of HIV in sub-Saharan 
Africa. There are, however, methodological obsta­
cles that also have prevented epidemiologists and 
public health practitioners from using the biomedi­
cal evidence described earlier in this essay. The in­
creasingly individual-level focus of medicine and 
public health was aggravated by the excessive reli­
ance on experimental and statistical methods that 
intentionally omit from consideration the context 
in which individual illness or population-wide out­
breaks occur.
AIDS discourse about Africa and HIV-prevention 
policy are derailed by confusion over what Rose calls 
"causes of cases and causes of incidence".52 Indi­
vidual risk factors that are associated only with one 
proximate cause (such as sex) do not fully explain 
why one individual becomes infected and another 
does not, nor do they explain why one population 
has higher incidence than another.
Poor nutrition, malaria, helminths and STIs 
make each sex act and each birth more risky in sub- 
Saharan Africa and accelerate epidemics of HIV in 
the region. By targeting only one proximate cause, 
sex, policy makers ignore the fundamentally differ­
ent distribution of risk factors between sub-Saharan 
Africa and affluent, temperate-zone regions. The 
'background noise' of an environment teeming with 
bacterial, viral, and parasitic cofactors is the appro­
priate object of study to understand causes of ele­
vated HIV risk for individuals and higher incidence 
in sub-Saharan Africa.
Methodological Handcuffs
Any causal explanation must involve some simpli­
fication, but randomized controlled trials (RCTs) 
are designed to evaluate the effects of just one sin­
gular cause. RCTs are essential in the evaluation of
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new drugs for which the effectiveness and harmful 
effects are unknown, but they are blunt instru­
ments for understanding infections or other 
pathologies that arise from multiple interacting 
causes, or evaluating public health interven­
tions.8889 Epidemics are complex systems; trials 
that attempt to change one part of that system may 
show unreliable results because of multiple causes 
and delayed effects.90,91
Trials of vitamin A supplementation for HIV- 
infected pregnant women reveal the difficulty of 
attempting to isolate one factor in a complex terrain. 
Observational studies indicated that women who 
were deficient in vitamin A were more likely to 
transmit HIV to their infants,92 but most trials of 
vitamin A supplementation failed to demonstrate a 
statistically significant difference in newborn 
infection,93 although one trial supported the 
hypothesis.94 Erroneously, some concluded that it is 
pointless to provide supplements to pregnant, 
vitamin-A deficient, HIV-infected women, in spite of 
known benefits of supplementation for women's 
health. Trial design permits only the conclusion that 
an intervention is or is not a unique solution. The 
trial cannot evaluate partial solutions or contributing 
causes. It does not matter how precise the answers are 
in such trials; their results are inaccurate because they 
do not include all causes. They are what physicists 
have called "not even wrong," because they do not 
ask the right questions and thus omit relevant data.
The STI-HIV Treatment Trials: Where Context 
Is Everything
Another example of the attempt to understand HIV 
without understanding its context is the case of the 
STI-HIV treatment trials. In the 1990s, a random­
ized controlled trial showed that even modest ef­
forts to improve the quality of diagnosis and care 
for STIs in Mwanza, Tanzania led to a nearly 
40 percent lower HIV incidence in communities 
with those interventions than in communities with­
out the interventions.95 Nevertheless, nine subse­
quent trials in diverse locations in sub-Saharan 
Africa using a variety of interventions did not find 
a statistically significant difference in HIV inci­
dence between two or more randomly selected 
groups. There were, however, methodological flaws
in each of those trials that make it invalid to draw 
policy conclusions from them. (For citations to all 
trials, see.)48
RCTs require clinical equipoise, which means 
that the researchers really do not know if the inter­
vention is beneficial, considering both its efficacy 
and its side effects. STIs are serious, sometimes dev­
astating diseases. Medications to treat almost all 
STIs were shown in earlier trials to be effective and 
have few side effects. Observational data and the 
Mwanza trial indicated, moreover, that STI treat­
ment could decrease HIV incidence. Consequently, 
ethical conduct in all the trials after Mwanza re­
quired that participants in both intervention and 
control groups in the study received STI treatments. 
There was thus little difference in exposure (the in­
terventions being tested) between the intervention 
and control groups and so one could expect little 
difference in HIV incidence between the two groups. 
In statistical terms, the post-Mwanza trials were un­
derpowered to detect a statistically significant dif­
ference in HIV incidence. Since it is impossible to 
construct ethical and meaningful RCTs to measure 
the impact of STI treatment on HIV transmission, it 
was inappropriate to throw out evidence from scores 
of observational studies that demonstrated the ef­
ficacy of STI treatments and the likelihood of reduc­
ing HIV incidence. STI treatment is a neglected 
intervention in HIV prevention and public health 
generally. (For examination of numerous other 
methodological problems with the 9 post-Mwanza 
trials, see.)48
Many policymakers also dismiss treatment of 
schistosomiasis as an HIV-prevention strategy, citing 
those same STI trials. There is no doubt that treating 
schistosomiasis would alleviate substantial urogeni­
tal morbidity and other health problems at low cost. 
What is contested is whether praziquantel should be 
a standard part of HIV prevention. The observed 
three- to four-fold increase in HIV acquisition in 
several studies39,96 suggests substantial attributable 
risk and should be sufficient to warrant wide imple­
mentation of praziquantel treatment. Given the high 
prevalence of schistosomiasis, over 120 million 
infected in sub-Saharan Africa, even a small increase 
in risk of HIV transm ission would generate very large 
numbers of new HIV infections.
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When an intervention is beneficial in itself, is 
safe, inexpensive, and logistically simple to admin­
ister in resource-poor settings, it does not make 
sense to impose the same burden of proof as one 
would for an intervention that is untested, or risky, 
or expensive, or complicated, such as for new drugs 
in the research phase.97-99
Emerging Understanding of Emerging 
Infectious Diseases
The mucosa of the genital tract is not a mere 
mechanical barrier. It is more accurate to refer to the 
microbial community of the genital tract as the 
ecosystem in which sex takes place. Poor genital 
health constitutes a disruption of vaginal microbial 
communities.91 STIs can cause lesions that later 
become infected with staphylococci and streptococci. 
Antibiotics for bacterial STIs are ineffective in 
treating those secondary infections. Treating 
schistosomiasis, or STIs, is clearly beneficial, as it 
begins the restoration of genital health. But each 
treatment taken in isolation might not register as 
statistically significant due to the presence of 
inflammation or lesions from other causes. Recovery 
of the environmental balance may well exceed the 
time frame of an RCT. The response to an inadequate 
statistical methodology should not be to reject a 
beneficial intervention.
The multiplicity of environmental risks could seem 
like an insurmountable barrier to HIV prevention.
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